Evolent Health, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Evolent Health, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-12-31 was -$1.00K, a 100.03% decline year-over-year.
- Evolent Health, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $2.34M, a 48.27% decline year-over-year.
- Evolent Health, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $60.00K, a 98.05% decline year-over-year.
- Evolent Health, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $1.06M, a 33.02% decline year-over-year.
- Evolent Health, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $3.46M, a 72.35% decline from fiscal 2023.
- Evolent Health, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $12.52M, a 181.20% increase from fiscal 2022.
- Evolent Health, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $4.45M, a 66.50% decline from fiscal 2021.
- Evolent Health, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $13.29M, a 415.68% increase from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $3.46M 10-K · filed 2026-02-25 |
| 2024-09-30 | $2.34M 10-Q · filed 2025-11-07 | $6.80M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $60.00K 10-Q · filed 2025-08-11 | $8.98M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $1.06M 10-Q · filed 2025-05-09 | $12.00M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $12.52M 10-K · filed 2026-02-25 |
| 2023-09-30 | $4.53M 10-Q · filed 2024-11-08 | $10.36M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $3.07M 10-Q · filed 2024-08-09 | $8.80M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $1.58M 10-Q · filed 2024-05-10 | $5.72M derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $4.45M 10-K · filed 2025-02-21 |
| 2022-09-30 | $2.97M 10-Q · filed 2023-11-02 | $5.00M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $4.22M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $309.00K 10-Q · filed 2023-05-04 | $7.08M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $13.29M 10-K · filed 2023-02-24 |
| 2021-09-30 | $2.19M 10-Q · filed 2022-11-03 | $12.17M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $2.86M 10-Q · filed 2022-08-03 | $11.43M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $6.52M 10-Q · filed 2022-05-05 | $9.01M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $603.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $2.58M 10-K · filed 2023-02-24 |
| 2020-09-30 | $1.45M 10-Q · filed 2021-11-04 | $2.07M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $443.00K 10-Q · filed 2021-08-05 | $671.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $84.00K 10-Q · filed 2021-05-06 | $1.05M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.09M 10-K · filed 2022-02-24 |
| 2019-09-30 | $49.00K 10-Q · filed 2020-11-06 | $2.34M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $823.00K 10-Q · filed 2020-08-07 | $8.18M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $123.00K 10-Q · filed 2020-05-28 | $10.59M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $11.93M 10-K · filed 2021-02-26 |
| 2018-09-30 | $5.89M 10-Q · filed 2019-11-05 | $10.87M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $3.23M 10-Q · filed 2019-08-09 | $5.21M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $1.46M 10-Q · filed 2019-05-09 | $5.00M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $280.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $4.08M 10-K · filed 2020-03-02 |
| 2017-09-30 | $242.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $3.82M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $3.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $4.71M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $542.00K 10-Q · filed 2017-05-10 | $1.78M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $1.26M 10-K · filed 2019-02-28 |
| 2016-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $1.30M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $89.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $228.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $25.00K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $152.00K 10-K · filed 2018-03-01 |
| 2015-09-30 | $54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |